The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Biosim­i­lar in­spec­tions still lag­ging as the FDA looks to clear its back­log

3 years ago
FDA+

Up­dat­ed: Span­ish he­parin man­u­fac­tur­er draws the ire of the FDA in its lat­est warn­ing over qual­i­ty con­cerns

3 years ago
FDA+

Pfiz­er to make ma­jor in­vest­ment in vac­cine R&D and man­u­fac­tur­ing site in New York

3 years ago
R&D

No­vavax fo­cus­es on vari­ant-spe­cif­ic vac­cines in ex­pand­ed deal with South Ko­re­an man­u­fac­tur­er

3 years ago
Pharma
Coronavirus

WuXi Bi­o­log­ics serves up $1.4B ex­pan­sion of re­search and man­u­fac­tur­ing cen­ter in Sin­ga­pore

3 years ago
Pharma

GSK nets a deal with Cana­di­an gov­ern­ment for flu vac­cine man­u­fac­tur­ing

3 years ago
Pharma

Mil­li­pore­Sig­ma us­es DOD funds to ex­pand Wis­con­sin-based man­u­fac­tur­ing site

3 years ago

Sam­sung’s CD­MO arm com­mits to $324M land pur­chase for a sec­ond bio cam­pus

3 years ago
Financing

US gov­ern­ment or­ders 2.5M more mon­key­pox vac­cine dos­es from Bavar­i­an Nordic via CMO

3 years ago
Pharma

Pfiz­er's Hos­pi­ra is­sues a re­call for a batch of propo­fol due to a vis­i­ble par­tic­u­late

3 years ago
Pharma
FDA+

Cana­di­an CRO Al­ta­sciences kicks off client man­u­fac­tur­ing ex­pan­sion in Philadel­phia

3 years ago

Man­u­fac­tur­ing roundup: FDA clears the way for more mon­key­pox vac­cines to be re­leased; Dis­cov­ery Life Sci­ence nets ac­qui­si­tion

3 years ago

Texas biotech ex­pands R&D and man­u­fac­tur­ing ca­pa­bil­i­ties fol­low­ing Catal­ent part­ner­ship

3 years ago
R&D

Amid glob­al ex­pan­sion, Sam­sung Bi­o­log­ics pledges emis­sions drops in new ESG re­port

3 years ago
Pharma

Ju­bi­lant Hol­lis­ter­Sti­er pumps $77M in­to Mon­tre­al fa­cil­i­ty to dou­ble its ca­pac­i­ty

3 years ago

Cal­i­for­nia to man­u­fac­ture and pro­duce its own in­sulin as Con­gress de­bates $35 month­ly cap

3 years ago
Pharma

FDA lifts hold on Green­wich Life­Sciences as biotech will forge ahead with im­munother­a­py drug can­di­date

3 years ago
Pharma
FDA+

Strug­gling biotech sells its API man­u­fac­tur­ing arm to nar­row its fo­cus

3 years ago
Financing
Pharma

Emer­gent nets an­oth­er man­u­fac­tur­ing deal, this time for Ridge­back­'s Ebo­la treat­ment

3 years ago
Deals
Pharma

An­oth­er In­di­an drug man­u­fac­tur­er hit with a Form 483 over re­cent ob­ser­va­tions

3 years ago
Pharma
FDA+

Ger­man chem­i­cals com­pa­ny to ex­pand its reach in­to mR­NA in­gre­di­ent pro­duc­tion

3 years ago
Pharma

Man­u­fac­tur­ing roundup: WuXi con­tin­ues its ex­pan­sion dri­ve with an­oth­er plant open­ing in Changzhou; Swiss biotech nets an­oth­er ac­qui­si­tion

3 years ago

Eu­ro­pean man­u­fac­tur­er Fa­gron ex­pands its US pres­ence by ac­quir­ing a fa­cil­i­ty on the East Coast

3 years ago
Deals

Lotte Group turns to Mer­ck KGaA’s US unit for leg up at new Syra­cuse bi­o­log­ics plant

3 years ago
Deals
Pharma
First page Previous page 47484950515253 Next page Last page
A service from the Financial Times